Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akoya Biosciences, Inc.

1.26
-0.0400-3.08%
Post-market: 1.260.00000.00%17:31 EDT
Volume:106.89K
Turnover:136.50K
Market Cap:62.84M
PE:-1.31
High:1.31
Open:1.31
Low:1.25
Close:1.30
Loading ...
Aug 05, 2024

Major Issues Report

Form 8-K - Current report
Jun 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2024

Major Issues Report

Form 8-K - Current report
Mar 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 05, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 10, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 03, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]